At close: March 3 at 8:00:16 AM EST ...
Targeted anti-angiogenic agents, such as sunitinib, have substantially improved the outcomes of patients with renal cell carcinoma (RCC); however, intrinsic and acquired resistance are both common and ...
There are no in the selected time period.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results